Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA.
Curr HIV Res. 2022;20(1):82-90. doi: 10.2174/1570162X19666211217093223.
People living with HIV (PLHIV) are at increased risk of COVID-19 acquisition, severe disease, and poor outcomes. Yet, little is known about COVID-19 vaccine hesitancy among PLHIV in high HIV burden countries, such as Nigeria.
This study aims to assess the acceptability of the COVID-19 vaccine and identify predictors and reasons for vaccine hesitancy among patients living with HIV and attending a tertiary hospital in Kano, northern Nigeria.
Using a mixed-methods design, structured questionnaires were administered to a clinic- based sample of patients living with HIV (n = 344), followed by 20 in-depth interviews with a sub-sample. Logistic regression and the framework approach were used to analyze the data.
Less than half (46.2 %, n = 159) of the respondents were willing to take the COVID-19 vaccine. Vaccine acceptance was higher among non-Muslim PLHIV (Adjusted Odds Ratio (aOR) = 1.26, 95 % Confidence Interval (95 % CI): 1.10-4.00), persons with high-risk perception (aOR = 2.43, 95 % CI:1.18-5.00), those who were not worried about infertility-related rumors (aOR = 13.54, 95 % CI:7.07-25.94) and persons who perceived antiretroviral drugs are protective against COVID-19 (aOR = 2.76, 95 % CI: 1.48-5.14). In contrast, vaccine acceptance was lower among persons who were not concerned about the potential effects of COVID-19-HIV co-infection (aOR = 0.20, 95 % CI:0.10-0.39). The most common reasons for vaccine hesitancy included doubts about the existence of COVID-19, low-risk perception, anxiety about antiretroviral treatmentvaccine interactions, safety concerns, and infertility-related rumors.
Covid-19 vaccine acceptance was low among PLHIV. COVID-19 vaccine acceptance was associated with respondents' faith, risk perception, perception of the protective effects of antiretroviral treatment, concerns about COVID-19-HIV co-infection, and infertility-related rumors. Vaccination counseling should be integrated into HIV treatment services to improve COVID-19 vaccine uptake among PLHIV in Kano, Nigeria and similar settings.
艾滋病毒感染者(PLHIV)感染 COVID-19、出现重症和不良结局的风险增加。然而,在像尼日利亚这样 HIV 负担沉重的国家,关于 PLHIV 对 COVID-19 疫苗的犹豫态度知之甚少。
本研究旨在评估 COVID-19 疫苗的可接受性,并确定在尼日利亚北部卡诺市一家三级医院就诊的 HIV 感染者中疫苗犹豫的预测因素和原因。
采用混合方法设计,对基于诊所的 HIV 感染者样本(n=344)进行了结构化问卷调查,随后对亚样本进行了 20 次深入访谈。使用逻辑回归和框架方法分析数据。
不到一半(46.2%,n=159)的受访者愿意接种 COVID-19 疫苗。非穆斯林 PLHIV(调整优势比(aOR)=1.26,95%置信区间(95%CI):1.10-4.00)、高危感知者(aOR=2.43,95%CI:1.18-5.00)、不担心与不孕相关谣言的人(aOR=13.54,95%CI:7.07-25.94)和认为抗逆转录病毒药物可预防 COVID-19 的人(aOR=2.76,95%CI:1.48-5.14)对疫苗的接受程度更高。相比之下,对 COVID-19-HIV 合并感染的潜在影响不关注的人(aOR=0.20,95%CI:0.10-0.39)对疫苗的接受程度较低。疫苗犹豫的最常见原因包括对 COVID-19 存在的怀疑、低风险感知、对抗逆转录病毒治疗疫苗相互作用的焦虑、安全性担忧以及与不孕相关的谣言。
PLHIV 对 COVID-19 疫苗的接受程度较低。COVID-19 疫苗的接受程度与受访者的信仰、风险感知、抗逆转录病毒治疗的保护作用感知、对 COVID-19-HIV 合并感染的担忧以及与不孕相关的谣言有关。应将疫苗接种咨询纳入 HIV 治疗服务,以提高尼日利亚卡诺和类似环境中 PLHIV 对 COVID-19 疫苗的接种率。